504. Targeted Genome Engineering of Induced Pluripotent Stem Cells To Produce Auto-Regulated Inflammation Resistance for Musculoskeletal Regenerative Medicine
Publication
, Conference
Brunger, JM; Zutshi, A; Willard, VP; Gersbach, CA; Guilak, F
Published in: Molecular Therapy
May 2015
Duke Scholars
Published In
Molecular Therapy
DOI
ISSN
1525-0016
Publication Date
May 2015
Volume
23
Start / End Page
S201 / S202
Publisher
Elsevier BV
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Brunger, J. M., Zutshi, A., Willard, V. P., Gersbach, C. A., & Guilak, F. (2015). 504. Targeted Genome Engineering of Induced Pluripotent Stem Cells To Produce Auto-Regulated Inflammation Resistance for Musculoskeletal Regenerative Medicine. In Molecular Therapy (Vol. 23, pp. S201–S202). Elsevier BV. https://doi.org/10.1016/s1525-0016(16)34113-2
Brunger, Jonathan M., Ananya Zutshi, Vincent P. Willard, Charles A. Gersbach, and Farshid Guilak. “504. Targeted Genome Engineering of Induced Pluripotent Stem Cells To Produce Auto-Regulated Inflammation Resistance for Musculoskeletal Regenerative Medicine.” In Molecular Therapy, 23:S201–2. Elsevier BV, 2015. https://doi.org/10.1016/s1525-0016(16)34113-2.
Brunger JM, Zutshi A, Willard VP, Gersbach CA, Guilak F. 504. Targeted Genome Engineering of Induced Pluripotent Stem Cells To Produce Auto-Regulated Inflammation Resistance for Musculoskeletal Regenerative Medicine. In: Molecular Therapy. Elsevier BV; 2015. p. S201–2.
Brunger, Jonathan M., et al. “504. Targeted Genome Engineering of Induced Pluripotent Stem Cells To Produce Auto-Regulated Inflammation Resistance for Musculoskeletal Regenerative Medicine.” Molecular Therapy, vol. 23, Elsevier BV, 2015, pp. S201–02. Crossref, doi:10.1016/s1525-0016(16)34113-2.
Brunger JM, Zutshi A, Willard VP, Gersbach CA, Guilak F. 504. Targeted Genome Engineering of Induced Pluripotent Stem Cells To Produce Auto-Regulated Inflammation Resistance for Musculoskeletal Regenerative Medicine. Molecular Therapy. Elsevier BV; 2015. p. S201–S202.
Published In
Molecular Therapy
DOI
ISSN
1525-0016
Publication Date
May 2015
Volume
23
Start / End Page
S201 / S202
Publisher
Elsevier BV
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences